192 related articles for article (PubMed ID: 30682092)
21. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
[TBL] [Abstract][Full Text] [Related]
22. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
Bjerrum L; Gahrn-Hansen B; Grinsted P
Scand J Prim Health Care; 2009; 27(1):6-11. PubMed ID: 18991182
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of pivmecillinam hydrochloride in lower urinary tract infections in pregnant women. Apropos of 44 cases].
Henrion R; Vige P
Rev Fr Gynecol Obstet; 1987 Dec; 82(12):761-4. PubMed ID: 3324273
[No Abstract] [Full Text] [Related]
24. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women.
Ejrnaes K; Sandvang D; Lundgren B; Ferry S; Holm S; Monsen T; Lundholm R; Frimodt-Moller N
J Clin Microbiol; 2006 May; 44(5):1776-81. PubMed ID: 16672406
[TBL] [Abstract][Full Text] [Related]
25. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
Mulder M; Verbon A; Lous J; Goessens W; Stricker BH
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2283-2290. PubMed ID: 31494829
[TBL] [Abstract][Full Text] [Related]
26. Long-term treatment with pivmecillinam in patients with recurrent bacteriuria.
Bresky B; Lincoln K
J Int Med Res; 1982; 10(3):179-82. PubMed ID: 6284565
[TBL] [Abstract][Full Text] [Related]
27. In-vitro sensitivity of organisms causing urinary tract infections to four common oral antibiotics and to pivmecillinam.
Bansal AS
West Indian Med J; 1988 Dec; 37(4):201-4. PubMed ID: 3266047
[No Abstract] [Full Text] [Related]
28. A fixed combination of pivmecillinam and pivampicillin in complicated urinary tract infections. A double-blind comparison with pivmecillinam.
Igesund A; Vorland L
Scand J Infect Dis; 1982; 14(2):159-60. PubMed ID: 6285450
[TBL] [Abstract][Full Text] [Related]
29. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.
Ferry SA; Holm SE; Stenlund H; Lundholm R; Monsen TJ
Scand J Prim Health Care; 2007 Mar; 25(1):49-57. PubMed ID: 17354160
[TBL] [Abstract][Full Text] [Related]
30. [Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam].
Bjerrum L; Dessau RB; Hallas J
Ugeskr Laeger; 2003 Sep; 165(39):3732-5. PubMed ID: 14558387
[No Abstract] [Full Text] [Related]
31. E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community.
McCowan C; Bakhshi A; McConnachie A; Malcolm W; Barry SJ; Santiago VH; Leanord A
BMC Infect Dis; 2022 Oct; 22(1):805. PubMed ID: 36307776
[TBL] [Abstract][Full Text] [Related]
32. The efficacy of pivmecillinam: 3 days or 5 days t.i.d against community acquired uncomplicated lower urinary tract infections - a randomized, double-blinded, placebo-controlled clinical trial study protocol.
Jansåker F; Frimodt-Møller N; Bjerrum L; Dahl Knudsen J
BMC Infect Dis; 2016 Dec; 16(1):727. PubMed ID: 27905884
[TBL] [Abstract][Full Text] [Related]
33. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with
Jansåker F; Boel JB; Thønnings S; Hertz FB; Hansen KH; Frimodt-Møller N; Knudsen JD
Infect Drug Resist; 2019; 12():1691-1702. PubMed ID: 31354318
[TBL] [Abstract][Full Text] [Related]
34. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.
Vik I; Bollestad M; Grude N; Bærheim A; Damsgaard E; Neumark T; Bjerrum L; Cordoba G; Olsen IC; Lindbæk M
PLoS Med; 2018 May; 15(5):e1002569. PubMed ID: 29763434
[TBL] [Abstract][Full Text] [Related]
35. Uncomplicated urinary tract infections in Swedish primary care; etiology, resistance and treatment.
Kornfält Isberg H; Melander E; Hedin K; Mölstad S; Beckman A
BMC Infect Dis; 2019 Feb; 19(1):155. PubMed ID: 30760219
[TBL] [Abstract][Full Text] [Related]
36. High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020.
Salm J; Salm F; Arendarski P; Kramer TS
Euro Surveill; 2022 Jul; 27(30):. PubMed ID: 35904060
[TBL] [Abstract][Full Text] [Related]
37. Comparison of antibiotic prescribing and antimicrobial resistance in urinary tract infections at the municipal level among women in two Nordic regions.
Nygaard Jensen J; Melander E; Hedin K; Bjerrum L; Kornfält Isberg H; Holm A; Neel Jacobsen H; Skovby A; Córdoba Currea GC; Hyllebusk L; Brogaard E; Arpi M
J Antimicrob Chemother; 2018 Aug; 73(8):2207-2214. PubMed ID: 29757408
[TBL] [Abstract][Full Text] [Related]
38. [Uncomplicated lower urinary tract infection: 3-day therapy is recommended!].
Mölstad S; Burman LG; Ferry S
Lakartidningen; 1999 Sep; 96(39):4212-4. PubMed ID: 10544588
[No Abstract] [Full Text] [Related]
39. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Meier S; Weber R; Zbinden R; Ruef C; Hasse B
Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
[TBL] [Abstract][Full Text] [Related]
40. Different patterns in use of antibiotics for lower urinary tract infection in institutionalized and home-dwelling elderly: a register-based study.
Haasum Y; Fastbom J; Johnell K
Eur J Clin Pharmacol; 2013 Mar; 69(3):665-71. PubMed ID: 22922683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
